BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26352143)

  • 1. An Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, India.
    Mogasale V; Kar SK; Kim JH; Mogasale VV; Kerketta AS; Patnaik B; Rath SB; Puri MK; You YA; Khuntia HK; Maskery B; Wierzba TF; Sah B
    PLoS Negl Trop Dis; 2015; 9(9):e0004072. PubMed ID: 26352143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
    Kar SK; Sah B; Patnaik B; Kim YH; Kerketta AS; Shin S; Rath SB; Ali M; Mogasale V; Khuntia HK; Bhattachan A; You YA; Puri MK; Lopez AL; Maskery B; Nair GB; Clemens JD; Wierzba TF
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2629. PubMed ID: 24516675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.
    Wierzba TF; Kar SK; Mogasale VV; Kerketta AS; You YA; Baral P; Khuntia HK; Ali M; Kim YH; Rath SB; Bhattachan A; Sah B
    Vaccine; 2015 May; 33(21):2463-9. PubMed ID: 25850019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.
    Khan IA; Saha A; Chowdhury F; Khan AI; Uddin MJ; Begum YA; Riaz BK; Islam S; Ali M; Luby SP; Clemens JD; Cravioto A; Qadri F
    Vaccine; 2013 Dec; 31(51):6058-64. PubMed ID: 24161413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia.
    Teshome S; Desai S; Kim JH; Belay D; Mogasale V
    Hum Vaccin Immunother; 2018; 14(10):2427-2433. PubMed ID: 29648523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh.
    Khan AI; Khan IA; Siddique SA; Rahman A; Islam MT; Bhuiya MAI; Saha NC; Biswas PK; Saha A; Chowdhury F; Qadri F
    Hum Vaccin Immunother; 2019; 15(6):1302-1309. PubMed ID: 30261152
    [No Abstract]   [Full Text] [Related]  

  • 7. Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India.
    Kar SK; Pach A; Sah B; Kerketta AS; Patnaik B; Mogasale V; Kim YH; Rath SB; Shin S; Khuntia HK; Bhattachan A; Puri MK; Wierzba TF; Kaljee LM
    Hum Vaccin Immunother; 2014; 10(10):2834-42. PubMed ID: 25483631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
    Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
    Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the costs of cholera illness and cost-effectiveness of a single dose oral vaccination campaign in Lusaka, Zambia.
    Tembo T; Simuyandi M; Chiyenu K; Sharma A; Chilyabanyama ON; Mbwili-Muleya C; Mazaba ML; Chilengi R
    PLoS One; 2019; 14(5):e0215972. PubMed ID: 31150406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.
    Khan AI; Islam MS; Islam MT; Ahmed A; Chowdhury MI; Chowdhury F; Siddik MAU; Clemens JD; Qadri F
    Vaccine; 2019 Feb; 37(6):827-832. PubMed ID: 30639459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh.
    Saha A; Hayen A; Ali M; Rosewell A; MacIntyre CR; Clemens JD; Qadri F
    Vaccine; 2018 Jul; 36(31):4742-4749. PubMed ID: 29752024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand.
    Phares CR; Date K; Travers P; Déglise C; Wongjindanon N; Ortega L; Bhuket PR
    Vaccine; 2016 Jan; 34(1):128-33. PubMed ID: 26549363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review.
    Mogasale V; Ramani E; Wee H; Kim JH
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005124. PubMed ID: 27930668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh.
    Sarker AR; Islam Z; Khan IA; Saha A; Chowdhury F; Khan AI; Cravioto A; Clemens JD; Qadri F; Khan JA
    Vaccine; 2015 Sep; 33(38):4916-21. PubMed ID: 26232545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-of-illness of cholera to households and health facilities in rural Malawi.
    Ilboudo PG; Huang XX; Ngwira B; Mwanyungwe A; Mogasale V; Mengel MA; Cavailler P; Gessner BD; Le Gargasson JB
    PLoS One; 2017; 12(9):e0185041. PubMed ID: 28934285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.
    Bhattacharya SK; Sur D; Ali M; Kanungo S; You YA; Manna B; Sah B; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Dhingra MS; Donner A; Nair GB; Lopez AL; Wierzba TF; Clemens JD
    Lancet Infect Dis; 2013 Dec; 13(12):1050-6. PubMed ID: 24140390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
    Khatib AM; Ali M; von Seidlein L; Kim DR; Hashim R; Reyburn R; Ley B; Thriemer K; Enwere G; Hutubessy R; Aguado MT; Kieny MP; Lopez AL; Wierzba TF; Ali SM; Saleh AA; Mukhopadhyay AK; Clemens J; Jiddawi MS; Deen J
    Lancet Infect Dis; 2012 Nov; 12(11):837-44. PubMed ID: 22954655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.
    Vu DT; Hossain MM; Nguyen DS; Nguyen TH; Rao MR; Do GC; Naficy A; Nguyen TK; Acosta CJ; Deen JL; Clemens JD; Dang DT
    J Health Popul Nutr; 2003 Dec; 21(4):304-8. PubMed ID: 15043004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery cost analysis of a reactive mass cholera vaccination campaign: a case study of Shanchol™ vaccine use in Lake Chilwa, Malawi.
    Ilboudo PG; Le Gargasson JB
    BMC Infect Dis; 2017 Dec; 17(1):779. PubMed ID: 29258447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis.
    Khan AI; Levin A; Chao DL; DeRoeck D; Dimitrov DT; Khan JAM; Islam MS; Ali M; Islam MT; Sarker AR; Clemens JD; Qadri F
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006652. PubMed ID: 30300420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.